Winton Group’s Arcus Biosciences RCUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-115,595
| Closed | -$907K | – | 976 |
|
|
2025
Q1 | $907K | Buy |
115,595
+43,285
| +60% | +$340K | 0.06% | 443 |
|
|
2024
Q4 | $1.08M | Buy |
72,310
+3,730
| +5% | +$55.5K | 0.07% | 297 |
|
|
2024
Q3 | $1.05M | Buy |
68,580
+9,443
| +16% | +$144K | 0.07% | 297 |
|
|
2024
Q2 | $901K | Buy |
59,137
+1,872
| +3% | +$28.5K | 0.06% | 321 |
|
|
2024
Q1 | $1.08M | Buy |
+57,265
| New | +$1.08M | 0.08% | 225 |
|
|
2022
Q1 | – | Sell |
-6,910
| Closed | -$280K | – | 1116 |
|
|
2021
Q4 | $280K | Buy |
+6,910
| New | +$280K | 0.02% | 855 |
|